Kibur Medical is a clinical-stage biomedical company revolutionizing the way we develop new therapies and select existing therapies for patients with cancer and other indications. Based on a proprietary implantable microdevice platform, we deploy single cell multi-omics to measure the response of a tumor directly in the body to multiple, individual drugs or drug combinations. This unique approach functionally profiles the drug-tumor response, without systemic exposure or pharmacokinetic optimization, for up to 100 therapies in a single tumor. Pre-clinical functional profiling services are offered through our partnership with Charles River Laboratories and Kibur Medical exclusively offers clinical functional profiling services.